Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer

NCT02316548 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT02316548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02316548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer
Lead sponsor
NRG Oncology
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2015
Completion date
February 1, 2017
Enrollment
14 (actual)
Sites
127

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii bladder cancer, stage iv bladder cancer